United States Generic Drugs Market Report 2017

United States Generic Drugs Market Report 2017

1 Generic Drugs Overview

1.1 Product Overview and Scope of Generic Drugs

1.2 Classification of Generic Drugs by Product Category

1.2.1 United States Generic Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Generic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Simple Generic Drugs

1.2.4 Super Generic Drugs

1.2.5 Biosimilars

1.3 United States Generic Drugs Market by Application/End Users

1.3.1 United States Generic Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 CNS

1.3.3 Cardiovascular

1.3.4 Genitourinary/Hormonal Drugs

1.3.5 Rheumatology

1.3.6 Oncology

1.4 United States Generic Drugs Market by Region

1.4.1 United States Generic Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Generic Drugs Status and Prospect (2012-2022)

1.4.3 Southwest Generic Drugs Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Generic Drugs Status and Prospect (2012-2022)

1.4.5 New England Generic Drugs Status and Prospect (2012-2022)

1.4.6 The South Generic Drugs Status and Prospect (2012-2022)

1.4.7 The Midwest Generic Drugs Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Generic Drugs (2012-2022)

1.5.1 United States Generic Drugs Sales and Growth Rate (2012-2022)

1.5.2 United States Generic Drugs Revenue and Growth Rate (2012-2022)

2 United States Generic Drugs Market Competition by Players/Suppliers

2.1 United States Generic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Generic Drugs Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Generic Drugs Average Price by Players/Suppliers (2012-2017)

2.4 United States Generic Drugs Market Competitive Situation and Trends

2.4.1 United States Generic Drugs Market Concentration Rate

2.4.2 United States Generic Drugs Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Generic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Generic Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Generic Drugs Sales and Market Share by Region (2012-2017)

3.2 United States Generic Drugs Revenue and Market Share by Region (2012-2017)

3.3 United States Generic Drugs Price by Region (2012-2017)

4 United States Generic Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Generic Drugs Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Generic Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Generic Drugs Price by Type (2012-2017)

4.4 United States Generic Drugs Sales Growth Rate by Type (2012-2017)

5 United States Generic Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Generic Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Generic Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Generic Drugs Players/Suppliers Profiles and Sales Data

6.1 Teva Pharma

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Generic Drugs Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Teva Pharma Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Novartis-Sandoz

6.2.2 Generic Drugs Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Novartis-Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Mylan

6.3.2 Generic Drugs Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Sun Pharmaceutical

6.4.2 Generic Drugs Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Aspen Pharmacare

6.5.2 Generic Drugs Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Aspen Pharmacare Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Allergan

6.6.2 Generic Drugs Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Allergan Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Fresenius Kabi

6.7.2 Generic Drugs Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Pfizer (Hospira)

6.8.2 Generic Drugs Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Sanofi

6.9.2 Generic Drugs Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Aurobindo

6.10.2 Generic Drugs Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Lupin

6.12 Dr. Reddy’s Lab

6.13 Apotex

6.14 Cipla

6.15 ENDO (Par Pharmaceutical)

6.16 Stada

6.17 Krka Group

6.18 Nichi-Iko Pharmaceutical

6.19 Valeant

6.20 Zydus Cadila

6.21 Hikma

7 Generic Drugs Manufacturing Cost Analysis

7.1 Generic Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Generic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Generic Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Generic Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Generic Drugs Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Generic Drugs Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Generic Drugs Sales Volume Forecast by Type (2017-2022)

11.3 United States Generic Drugs Sales Volume Forecast by Application (2017-2022)

11.4 United States Generic Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Generic Drugs

Figure United States Generic Drugs Market Size (K MT) by Type (2012-2022)

Figure United States Generic Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Simple Generic Drugs Product Picture

Figure Super Generic Drugs Product Picture

Figure Biosimilars Product Picture

Figure United States Generic Drugs Market Size (K MT) by Application (2012-2022)

Figure United States Sales Market Share of Generic Drugs by Application in 2016

Figure CNS Examples

Figure Cardiovascular Examples

Figure Genitourinary/Hormonal Drugs Examples

Figure Rheumatology Examples

Figure Oncology Examples

Figure United States Generic Drugs Market Size (Million USD) by Region (2012-2022)

Figure The West Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Generic Drugs Sales (K MT) and Growth Rate (2012-2022)

Figure United States Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Generic Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)

Table United States Generic Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)

Table United States Generic Drugs Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Generic Drugs Sales Share by Players/Suppliers

Figure 2017 United States Generic Drugs Sales Share by Players/Suppliers

Figure United States Generic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Generic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Generic Drugs Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Generic Drugs Revenue Share by Players/Suppliers

Figure 2017 United States Generic Drugs Revenue Share by Players/Suppliers

Table United States Market Generic Drugs Average Price (USD/MT) of Key Players/Suppliers (2012-2017)

Figure United States Market Generic Drugs Average Price (USD/MT) of Key Players/Suppliers in 2016

Figure United States Generic Drugs Market Share of Top 3 Players/Suppliers

Figure United States Generic Drugs Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Generic Drugs Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Generic Drugs Product Category

Table United States Generic Drugs Sales (K MT) by Region (2012-2017)

Table United States Generic Drugs Sales Share by Region (2012-2017)

Figure United States Generic Drugs Sales Share by Region (2012-2017)

Figure United States Generic Drugs Sales Market Share by Region in 2016

Table United States Generic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Generic Drugs Revenue Share by Region (2012-2017)

Figure United States Generic Drugs Revenue Market Share by Region (2012-2017)

Figure United States Generic Drugs Revenue Market Share by Region in 2016

Table United States Generic Drugs Price (USD/MT) by Region (2012-2017)

Table United States Generic Drugs Sales (K MT) by Type (2012-2017)

Table United States Generic Drugs Sales Share by Type (2012-2017)

Figure United States Generic Drugs Sales Share by Type (2012-2017)

Figure United States Generic Drugs Sales Market Share by Type in 2016

Table United States Generic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Generic Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Generic Drugs by Type (2012-2017)

Figure Revenue Market Share of Generic Drugs by Type in 2016

Table United States Generic Drugs Price (USD/MT) by Types (2012-2017)

Figure United States Generic Drugs Sales Growth Rate by Type (2012-2017)

Table United States Generic Drugs Sales (K MT) by Application (2012-2017)

Table United States Generic Drugs Sales Market Share by Application (2012-2017)

Figure United States Generic Drugs Sales Market Share by Application (2012-2017)

Figure United States Generic Drugs Sales Market Share by Application in 2016

Table United States Generic Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Generic Drugs Sales Growth Rate by Application (2012-2017)

Table Teva Pharma Basic Information List

Table Teva Pharma Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Teva Pharma Generic Drugs Sales Growth Rate (2012-2017)

Figure Teva Pharma Generic Drugs Sales Market Share in United States (2012-2017)

Figure Teva Pharma Generic Drugs Revenue Market Share in United States (2012-2017)

Table Novartis-Sandoz Basic Information List

Table Novartis-Sandoz Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Novartis-Sandoz Generic Drugs Sales Growth Rate (2012-2017)

Figure Novartis-Sandoz Generic Drugs Sales Market Share in United States (2012-2017)

Figure Novartis-Sandoz Generic Drugs Revenue Market Share in United States (2012-2017)

Table Mylan Basic Information List

Table Mylan Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Mylan Generic Drugs Sales Growth Rate (2012-2017)

Figure Mylan Generic Drugs Sales Market Share in United States (2012-2017)

Figure Mylan Generic Drugs Revenue Market Share in United States (2012-2017)

Table Sun Pharmaceutical Basic Information List

Table Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Sun Pharmaceutical Generic Drugs Sales Growth Rate (2012-2017)

Figure Sun Pharmaceutical Generic Drugs Sales Market Share in United States (2012-2017)

Figure Sun Pharmaceutical Generic Drugs Revenue Market Share in United States (2012-2017)

Table Aspen Pharmacare Basic Information List

Table Aspen Pharmacare Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Aspen Pharmacare Generic Drugs Sales Growth Rate (2012-2017)

Figure Aspen Pharmacare Generic Drugs Sales Market Share in United States (2012-2017)

Figure Aspen Pharmacare Generic Drugs Revenue Market Share in United States (2012-2017)

Table Allergan Basic Information List

Table Allergan Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Allergan Generic Drugs Sales Growth Rate (2012-2017)

Figure Allergan Generic Drugs Sales Market Share in United States (2012-2017)

Figure Allergan Generic Drugs Revenue Market Share in United States (2012-2017)

Table Fresenius Kabi Basic Information List

Table Fresenius Kabi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Fresenius Kabi Generic Drugs Sales Growth Rate (2012-2017)

Figure Fresenius Kabi Generic Drugs Sales Market Share in United States (2012-2017)

Figure Fresenius Kabi Generic Drugs Revenue Market Share in United States (2012-2017)

Table Pfizer (Hospira) Basic Information List

Table Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Pfizer (Hospira) Generic Drugs Sales Growth Rate (2012-2017)

Figure Pfizer (Hospira) Generic Drugs Sales Market Share in United States (2012-2017)

Figure Pfizer (Hospira) Generic Drugs Revenue Market Share in United States (2012-2017)

Table Sanofi Basic Information List

Table Sanofi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Sanofi Generic Drugs Sales Growth Rate (2012-2017)

Figure Sanofi Generic Drugs Sales Market Share in United States (2012-2017)

Figure Sanofi Generic Drugs Revenue Market Share in United States (2012-2017)

Table Aurobindo Basic Information List

Table Aurobindo Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Aurobindo Generic Drugs Sales Growth Rate (2012-2017)

Figure Aurobindo Generic Drugs Sales Market Share in United States (2012-2017)

Figure Aurobindo Generic Drugs Revenue Market Share in United States (2012-2017)

Table Lupin Basic Information List

Table Dr. Reddy’s Lab Basic Information List

Table Apotex Basic Information List

Table Cipla Basic Information List

Table ENDO (Par Pharmaceutical) Basic Information List

Table Stada Basic Information List

Table Krka Group Basic Information List

Table Nichi-Iko Pharmaceutical Basic Information List

Table Valeant Basic Information List

Table Zydus Cadila Basic Information List

Table Hikma Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Generic Drugs

Figure Manufacturing Process Analysis of Generic Drugs

Figure Generic Drugs Industrial Chain Analysis

Table Raw Materials Sources of Generic Drugs Major Players/Suppliers in 2016

Table Major Buyers of Generic Drugs

Table Distributors/Traders List

Figure United States Generic Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure United States Generic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Generic Drugs Price (USD/MT) Trend Forecast (2017-2022)

Table United States Generic Drugs Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Generic Drugs Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Generic Drugs Sales Volume (K MT) Forecast by Type in 2022

Table United States Generic Drugs Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Generic Drugs Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Generic Drugs Sales Volume (K MT) Forecast by Application in 2022

Table United States Generic Drugs Sales Volume (K MT) Forecast by Region (2017-2022)

Table United States Generic Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Generic Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Generic Drugs Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources